“…In nine studies, stages 0-I, II, and III were reported in 51.7%, 38.9%, and 9.4% of the cases, respectively (21,24,25,27,29,31,33,35,36). In five studies that reported T-stage, T1, T2, and T3 tumors were in 60.2%, 35.2%, and 4.4% of the cases, respectively (22,26,28,37,38). N0, N1, and N2 disease was reported in 65.1%, 24.8%, and 10% of the patients, respectively (26,28,37,38).…”